FDA Annual Device Registration Renewal: Deadlines, Fees, and the Cost of Missing the October 1–December 31 Window

FDA Annual Registration Renewal: What Every Device Company Needs to Know Before October 1

Every year, without exception, FDA-registered medical device establishments must renew their registration during a single, fixed window: October 1 through December 31. Miss it, and you are not simply late on paperwork. You are operating an unregistered establishment, which carries real regulatory and commercial consequences. If you are a startup founder preparing for your first renewal, or a VP of Regulatory Affairs managing multiple sites, this post breaks down exactly what is required, what it costs, and what happens when companies fall through the cracks.

The Regulatory Foundation: 21 CFR Part 807

The requirement to register with FDA is codified under 21 CFR Part 807, Subpart B. Under 21 CFR 807.21, domestic device establishments must register annually. Foreign establishments distributing devices into the United States carry the same obligation under 21 CFR 807.40. The Federal Food, Drug, and Cosmetic Act (FD&C Act), Section 510, is the statutory authority underlying all of this — which is why device establishment registration is often called a '510 registration,' entirely distinct from a 510(k) premarket clearance.

FDA operationalizes annual renewal through its Unified Registration and Listing System (FURLS), accessed via the FDA Industry Systems portal. Renewals completed outside the October 1 to December 31 window are not accepted for the current fiscal year cycle. There is no grace period and no formal extension mechanism.

The Annual User Fee: What You Owe and When

Annual registration is not free. FDA assesses a Medical Device Establishment Registration User Fee authorized under Section 738 of the FD&C Act. The fee is recalculated each fiscal year. For FY2025, FDA set the standard annual establishment registration fee at $7,653. FDA publishes the updated fee each year in the Federal Register, typically in late summer ahead of the October 1 renewal opening.

Key fee facts every registrant should know:

• Payment is required before registration is considered complete. Submitting your renewal in FURLS without paying the fee does not constitute valid registration.
• Small businesses may qualify for a reduced fee. Under 21 CFR 807 and the Small Business Regulatory Relief provisions, establishments that meet FDA's definition of a small business — generally less than $100 million in gross receipts — may pay a reduced rate. The FY2025 small business fee was $1,913. You must pre-qualify through FDA's Center for Devices and Radiological Health (CDRH) and receive a Small Business Determination before submitting payment at the reduced rate.
• Fee waivers are available in limited circumstances, including for certain foreign governments and nonprofit entities, but these are narrow exceptions, not the norm.
• Device listing (21 CFR Part 807, Subpart D) is linked to registration and must also be current. Listing itself carries no separate user fee, but an invalid registration invalidates your listing status.

What Actually Happens If You Miss the Window

This is where founders and regulatory teams sometimes underestimate the stakes. FDA does not send a warning letter the moment your registration lapses — but the downstream consequences are immediate and compounding.

Your establishment becomes unregistered. Under 21 CFR 807.20, operating a device establishment without a valid registration is a prohibited act under Section 301(p) of the FD&C Act. FDA can initiate regulatory action including Warning Letters, import alerts for foreign establishments, and in serious cases, injunctive action.

Import and distribution disruptions are real. If you are a foreign establishment and your registration lapses, FDA's Operational and Administrative System for Import Support (OASIS) will flag your shipments. Products can be detained at the border — a business-stopping event if you are mid-launch or scaling a commercial line.

Contract and procurement consequences. Many hospital systems, group purchasing organizations (GPOs), and distributors require current FDA registration as a contractual condition. A lapsed registration discovered during a supplier audit can cost you the contract.

Inspection readiness is impacted. If FDA selects your establishment for a routine inspection under 21 CFR Part 820 and your registration is not current, that discrepancy will be documented. It signals to the investigator that your quality system may have broader compliance gaps.

Practical Steps to Stay Ahead of the October 1 Deadline

The renewal window opens October 1 — not October 15, not 'sometime in Q4.' Build these actions into your regulatory calendar now:

• Verify your FURLS account access in September. Account lockouts and forgotten credentials are a surprisingly common reason companies miss the window. Confirm your FDA Industry Systems login is active and that the right team members have account access.
• Confirm your Small Business Determination status. If you qualified for a reduced fee last year, that determination does not automatically roll over. Reapply early if your financials still qualify.
• Audit your device listings before renewal. Annual registration is your opportunity to ensure all listed devices are accurate and current under 21 CFR 807.26. Discontinued devices should be delisted; new devices added post-clearance must appear.
• Budget the fee in Q3. Finance teams that are not familiar with FDA user fees sometimes flag the registration payment as unexpected. Get it into the budget cycle before it becomes an accounts-payable scramble in November.
• Set calendar reminders for October 1 and December 1. The December 1 reminder gives you four weeks of runway to resolve any payment or system issues before the December 31 hard close.

The Bottom Line

FDA annual registration renewal is one of the most administratively straightforward compliance obligations device companies face — but it is also one of the most commonly fumbled, especially at early-stage companies where regulatory bandwidth is stretched thin. The October 1 to December 31 window is fixed, the fees are non-negotiable, and the consequences of lapsing are immediate. Treat this deadline with the same urgency you give your 510(k) submission or your ISO 13485 surveillance audit.

At ADB Consulting and CRO Inc., we work with medical device startups and established manufacturers to keep their regulatory programs current, audit-ready, and commercially uninterrupted. Whether you need support managing your annual registration, conducting a listing audit, or navigating a lapsed registration situation, our team is here to help you stay compliant and move forward with confidence.

Ready to make sure your registration is handled correctly this cycle? Book a free discovery call with Andre Butler and the ADB Consulting team at adbccro.com today.

Related reading: our FDA establishment registration and listing service covers this in more depth.